Taken together, four of five HCC cell lines have an operational TGF-β/Smad signaling pathway and are growth inhibited by exogenous TGF-β1 to varying degrees in both two dimensional and three dimensional growth conditions. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.